Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression. Nishida J, Cristea S, Bodapati S, Puleo J, et al. Proc Natl Acad Sci U S A 2023;120:e2316763120.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nishida J, Cristea S, Bodapati S, Puleo J, et al. Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression. Proc Natl Acad Sci U S A 2023;120:e2316763120.
PMID: 38011567